Pharmacy Benefit Managers (PBMs) are hidden intermediaries in the pharmaceutical supply chain, driving up the cost of prescription drugs, delaying access to needed care and robbing patients of hope. It’s time to draw the curtain on these insidious actors.
Today, the House Oversight and Accountability Committee will meet for the first time ever. hearing With PBM, we’re trying to answer a fundamental question: is this business in business for people or for profit?
Here it is What you need to know To answer that question:
Pulling the Curtain on PBM: A Path to Affordable Prescription Drugs
 |
Read my full report on PBM practices here
Last year, I interviewed patients across the country about how PBM hinders access to treatment and ultimately keeps them ill—the exact opposite of what they should be doing. Learned in detail.
Here you can read and watch their stories and my first report published in the Harvard Legislative Journal.
 |
in the news
 |
Read the MedPage Today article here
on screen
How do pharmacists feel about PBM?
 |
Read the full survey results here
Read my full report and patient testimonials here.
You can view the Oversight and Accountability Committee hearings here.